Resources
-
Streamlining Analytical Platform Procedures:
Addressing Early Phase Development Challenges
Speaker Presentation: Virtual Europe Discussion Group 2025
Eggink Mark, Byondis, 2025 -
Retrospective Establishment of Platform
Analytical Procedures
Speaker Presentation: Virtual Europe Discussion Group 2025
Milford Mark, Eli Lilly and Company, 2025 -
Commercial Submission Considerations for Platform Analytical Procedures
Speaker Presentation: Virtual Europe Discussion Group 2025
Rule Karen, Pfizer, Inc., 2025 -
Comparability of
Alternative
Procedures
Speaker Presentation: Netherlands Area Biotech Discussion Group 2025
Spieldenner Bruno, EDQM, 2025 -
IQ Biologics Specifications Setting Challenges and Opportunities Working Group Endotoxin Subgroup Readout
Speaker Presentation: CMC Strategy Forum North America 2025
Kearns Katrina, Pfizer, Inc., 2025 -
Bridges Over Multiple Biotech Corridors
Speaker Presentation: Bioassays 2025
Weil Dylan, AstraZeneca, 2025 -
Afucosylation:
Potency Evaluation Strategies
Speaker Presentation: Bioassays 2025
Swiss Victoria, Bristol-Myers Squibb Company, 2025 -
Development of a New Class of Target Cell Lines to Evaluate Fc-mediated Cytotoxicity
Speaker Presentation: Bioassays 2025
Vendor Showcase, Svar Life Science, 2025 -
PLA 3.0 – Latest Developments
Speaker Presentation: Bioassays 2025
Vendor Showcase, Stegmann Systems, 2025 -
Quantitative Cellular PAT Analytics Driving Improvements in Advanced Therapy Process and Production Outcomes
Speaker Presentation: Bioassays 2025
Vendor Showcase, LumaCyte, Inc., 2025 -
DPX Technologies - Delivering Purification Excellence
Speaker Presentation: Bioassays 2025
Vendor Showcase, DPX Technologies, 2025 -
We are Catalent
Speaker Presentation: Bioassays 2025
Vendor Showcase, Catalent, 2025 -
BioAgilytix - Global Footprint, Local Resources
Speaker Presentation: Bioassays 2025
Vendor Showcase, BioAgilytix, 2025 -
5 Good Reasons to Use Assay Ready InstaCELLs
Speaker Presentation: Bioassays 2025
Vendor Showcase, acCELLerate, 2025 -
Navigating Complexity: A Strategic Framework
for Streamlining and Simplifying Antibody Drug
Conjugates Development and Potency Assay
Lifecycle Management
Speaker Presentation: Bioassays 2025
Toulokhonova Larisa, Merck & Co., Inc., 2025 -
Of Mice and (Wo)Men
Speaker Presentation: Bioassays 2025
Tomaschek Simone, Roche Diagnostics GmbH, 2025 -
Potency Revolution: MoA-Reflective Bioassays for
Next-Gen QC Testing
Speaker Presentation: Bioassays 2025
Takayanagi Ayumi, Chugai Pharmaceutical Co., Ltd., 2025 -
Elranatamab: Bispecific
mAb Bioassay Strategy
from R&D to
Commercialization
Speaker Presentation: Bioassays 2025
Richard Peter, Pfizer, Inc., 2025 -
Use of High Content Imaging to Enable Cell-based Potency Assay Development for ADCs
Speaker Presentation: Bioassays 2025
Mukherjee Madhumati, AstraZeneca, 2025 -
The Special World of Bioassay - Approach/Setup, Special Situations and Keys to Success
Speaker Presentation: Bioassays 2025
Mozier Ned, Pfizer, Inc. (Retired), 2025